
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Oncol. , 22 August 2022
Sec. Gastrointestinal Cancers: Colorectal Cancer
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.1012871
This article is a correction to:
Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression
A corrigendum on
Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression
By Zhang D, Huang H, Zheng T, Zhang L, Cui B, Liu Y, Tan S, Zhao L, Tian T, Gao L, Fu Q, Cheng Z and Zhao Y (2022) 12:924988. doi: 10.3389/fonc.2022.924988
In the published article, there was an error in Figure 4 as published. The microscopy slides of migration of “Vector” group and “PIGR+ LAMB3” group were misused in Figure 4G due to carelessness. The corrected Figure 4 and its caption appear below.
Figure 4 PIGR suppresses AKT-FOXO3/4 axis through LAMB3 (A) Relative LAMB3 mRNA expression of empty vector (Vector), PIGR-overexpressing (PIGR), LAMB3-overexpressing (LAMB3) and rescue experiment group (PIGR & LAMB3) in RKO and HCT-8 cells. Differences compared to Vector group (n = 3; one-way ANOVA, P adjusted by FDR). (B) Cell proliferation was detected by CCK-8 assay at 0, 24, 48, 72 and 96 hours in RKO and HCT-8 cells (n = 3; one-way ANOVA, P adjusted by FDR). (C) The colony formation assay of RKO and HCT-8 cells (n = 3; one-way ANOVA, P adjusted by FDR). (D–G) Wound healing, migration, and invasion assays were performed in RKO and HCT-8 cells (n = 3; one-way ANOVA, P adjusted by FDR). (H, I) Western blot showed altered protein levels of AKT-FOXO3/4 axis in empty vector, PIGR-overexpressing, LAMB3- overexpressing and rescue experiment group in RKO and HCT-8 cells. Differences compared to Vector group. Data are presented as the mean ± S.D. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: colorectal cancer, polymeric immunoglobulin receptor, prognostic marker, AKTFOXO3/4 axis, methylation-driven gene
Citation: Zhang D, Huang H, Zheng T, Zhang L, Cui B, Liu Y, Tan S, Zhao L, Tian T, Gao L, Fu Q, Cheng Z and Zhao Y (2022) Corrigendum: Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression. Front. Oncol. 12:1012871. doi: 10.3389/fonc.2022.1012871
Received: 06 August 2022; Accepted: 08 August 2022;
Published: 22 August 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Zhang, Huang, Zheng, Zhang, Cui, Liu, Tan, Zhao, Tian, Gao, Fu, Cheng and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yashuang Zhao, emhhb195YXNodWFuZ0AyNjMubmV0
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.